{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T10:06:02Z","timestamp":1781777162402,"version":"3.54.5"},"reference-count":88,"publisher":"Baishideng Publishing Group Inc.","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2009]]},"DOI":"10.3748\/wjg.15.2701","type":"journal-article","created":{"date-parts":[[2009,6,13]],"date-time":"2009-06-13T02:45:05Z","timestamp":1244861105000},"page":"2701","source":"Crossref","is-referenced-by-count":69,"title":["Helicobacter pylori infection and endocrine disorders: Is there a link?"],"prefix":"10.3748","volume":"15","author":[{"given":"Konstantinos X","family":"Papamichael","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garyphallia","family":"Papaioannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Karga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios","family":"Roussos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerassimos J","family":"Mantzaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991;338:1175-1176.","DOI":"10.1016\/0140-6736(91)92035-Z"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Parsonnet J. Helicobacter pylori and gastric cancer. Gastroenterol Clin North Am 1993;22:89-104.","DOI":"10.1016\/S0889-8553(21)00265-X"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Graham DY, Osato MS, Olson CA, Zhang J, Figura N. Effect of H. pylori infection and CagA status on leukocyte counts and liver function tests: extra-gastric manifestations of H. pylori infection. Helicobacter 1998;3:174-178.","DOI":"10.1046\/j.1523-5378.1998.08018.x"},{"key":"ref4","unstructured":"Perri F, Clemente R, Festa V, De Ambrosio CC, Quitadamo M, Fusillo M, Grossi E, Andriulli A. Serum tumour necrosis factor-alpha is increased in patients with Helicobacter pylori infection and CagA antibodies. Ital J Gastroenterol Hepatol 1999;31:290-294."},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Patel P, Mendall MA, Khulusi S, Northfield TC, Strachan DP. Helicobacter pylori infection in childhood: risk factors and effect on growth. BMJ 1994;309:1119-1123.","DOI":"10.1136\/bmj.309.6962.1119"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Oldenburg B, Diepersloot RJ, Hoekstra JB. High seroprevalence of Helicobacter pylori in diabetes mellitus patients. Dig Dis Sci 1996;41:458-461.","DOI":"10.1007\/BF02282318"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Gasbarrini A, Ojetti V, Pitocco D, De Luca A, Franceschi F, Candelli M, Sanz Torre E, Pola P, Ghirlanda G, Gasbarrini G. Helicobacter pylori infection in patients affected by insulin-dependent diabetes mellitus. Eur J Gastroenterol Hepatol 1998;10:469-472.","DOI":"10.1097\/00042737-199806000-00006"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Salardi S, Cacciari E, Menegatti M, Landi F, Mazzanti L, Stella FA, Pirazzoli P, Vaira D. Helicobacter pylori and type 1 diabetes mellitus in children. J Pediatr Gastroenterol Nutr 1999;28:307-309.","DOI":"10.1097\/00005176-199903000-00017"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Arslan D, Kendirci M, Kurtoglu S, Kula M. Helicobacter pylori infection in children with insulin dependent diabetes mellitus. J Pediatr Endocrinol Metab 2000;13:553-556.","DOI":"10.1515\/JPEM.2000.13.5.553"},{"key":"ref10","unstructured":"Perdichizzi G, Bottari M, Pallio S, Fera MT, Carbone M, Barresi G. Gastric infection by Helicobacter pylori and antral gastritis in hyperglycemic obese and in diabetic subjects. New Microbiol 1996;19:149-154."},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Senturk O, Canturk Z, Cetinarslan B, Ercin C, Hulagu S, Canturk NZ. Prevalence and comparisons of five different diagnostic methods for Helicobacter pylori in diabetic patients. Endocr Res 2001;27:179-189.","DOI":"10.1081\/ERC-100107179"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Quatrini M, Boarino V, Ghidoni A, Baldassarri AR, Bianchi PA, Bardella MT. Helicobacter pylori prevalence in patients with diabetes and its relationship to dyspeptic symptoms. J Clin Gastroenterol 2001;32:215-217.","DOI":"10.1097\/00004836-200103000-00006"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Gulcelik NE, Kaya E, Demirbas B, Culha C, Koc G, Ozkaya M, Cakal E, Serter R, Aral Y. Helicobacter pylori prevalence in diabetic patients and its relationship with dyspepsia and autonomic neuropathy. J Endocrinol Invest 2005;28:214-217.","DOI":"10.1007\/BF03345375"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Gentile S, Turco S, Oliviero B, Torella R. The role of autonomic neuropathy as a risk factor of Helicobacter pylori infection in dyspeptic patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 1998;42:41-48.","DOI":"10.1016\/S0168-8227(98)00088-6"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Persico M, Suozzo R, De Seta M, Montella F, Torella R, Gentile S. Non-ulcer dyspepsia and Helicobacter pylori in type 2 diabetic patients: association with autonomic neuropathy. Diabetes Res Clin Pract 1996;31:87-92.","DOI":"10.1016\/0168-8227(96)01207-7"},{"key":"ref16","unstructured":"Quadri R, Rossi C, Catalfamo E, Masoero G, Lombardo L, Della Monica P, Rovera L, Pera A, Cavello Perin P. Helicobacter pylori infection in type 2 diabetic patients. Nutr Metab Cardiovasc Dis 2000;10:263-266."},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Anastasios R, Goritsas C, Papamihail C, Trigidou R, Garzonis P, Ferti A. Helicobacter pylori infection in diabetic patients: prevalence and endoscopic findings. Eur J Intern Med 2002;13:376.","DOI":"10.1016\/S0953-6205(02)00094-8"},{"key":"ref18","unstructured":"Kozak R, Juhasz E, Horvat G, Harcsa E, Lovei L, Sike R, Szele K. [Helicobacter pylori infection in diabetic patients]. Orv Hetil 1999;140:993-995."},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Ko GT, Chan FK, Chan WB, Sung JJ, Tsoi CL, To KF, Lai CW, Cockram CS. Helicobacter pylori infection in Chinese subjects with type 2 diabetes. Endocr Res 2001;27:171-177.","DOI":"10.1081\/ERC-100107178"},{"key":"ref20","unstructured":"Ojetti V, Pitocco D, Ghirlanda G, Gasbarrini G, Gasbarrini A. [Role of Helicobacter pylori infection in insulin-dependent diabetes mellitus]. Minerva Med 2001;92:137-144."},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Xia HH, Talley NJ, Kam EP, Young LJ, Hammer J, Horowitz M. Helicobacter pylori infection is not associated with diabetes mellitus, nor with upper gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol 2001;96:1039-1046.","DOI":"10.1111\/j.1572-0241.2001.03604.x"},{"key":"ref22","unstructured":"Stanciu OG, Trifan A, Sfarti C, Cojocariu C, Stanciu C. Helicobacter pylori infection in patients with diabetes mellitus. Rev Med Chir Soc Med Nat Iasi 2003;107:59-65."},{"key":"ref23","unstructured":"Zelenkova J, Souckova A, Kvapil M, Soucek A, Vejvalka J, Segethova J. [Helicobacter pylori and diabetes mellitus]. Cas Lek Cesk 2002;141:575-577."},{"key":"ref24","unstructured":"Kojecky V, Roubalik J, Bartonikova N. [Helicobacter pylori in patients with diabetes mellitus]. Vnitr Lek 1993;39:581-584."},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Jones KL, Wishart JM, Berry M, Russo A, Xia HH, Talley NJ, Horowitz M. Helicobacter pylori infection is not associated with delayed gastric emptying or upper gastrointestinal symptoms in diabetes mellitus. Dig Dis Sci 2002;47:704-709.","DOI":"10.1023\/A:1014763210890"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Marrollo M, Latella G, Melideo D, Storelli E, Iannarelli R, Stornelli P, Valenti M, Caprilli R. Increased prevalence of Helicobacter pylori in patients with diabetes mellitus. Dig Liver Dis 2001;33:21-29.","DOI":"10.1016\/S1590-8658(01)80131-6"},{"key":"ref27","unstructured":"Malecki M, Bien AI, Galicka-Latala D, Klupa T, Stachura J, Sieradzki J. [Reactive gastritis in patients with diabetics with dyspeptic symptoms]. Przegl Lek 1996;53:540-543."},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Pietroiusti A, Giuliano M, Magrini A, Bergamaschi A, Galante A. Cytotoxin-associated gene A strains of Helicobacter pylori represent a risk factor for the development of microalbuminuria in type 2 diabetes. Diabetes Care 2006;29:1399-1401.","DOI":"10.2337\/dc06-0404"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"de Luis DA, Lahera M, Canton R, Boixeda D, San Roman AL, Aller R, de La Calle H. Association of Helicobacter pylori infection with cardiovascular and cerebrovascular disease in diabetic patients. Diabetes Care 1998;21:1129-1132.","DOI":"10.2337\/diacare.21.7.1129"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Gasbarrini A, Ojetti V, Pitocco D, Franceschi F, Candelli M, Torre ES, Gabrielli M, Cammarota G, Armuzzi A, Pola R. Insulin-dependent diabetes mellitus affects eradication rate of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1999;11:713-716.","DOI":"10.1097\/00042737-199907000-00005"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Gasbarrini A, Ojetti V, Pitocco D, Armuzzi A, Silveri NG, Pola P, Ghirlanda G, Gasbarrini G. Efficacy of different Helicobacter pylori eradication regimens in patients affected by insulin-dependent diabetes mellitus. Scand J Gastroenterol 2000;35:260-263.","DOI":"10.1080\/003655200750024119"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Sargyn M, Uygur-Bayramicli O, Sargyn H, Orbay E, Yavuzer D, Yayla A. Type 2 diabetes mellitus affects eradication rate of Helicobacter pylori. World J Gastroenterol 2003;9:1126-1128.","DOI":"10.3748\/wjg.v9.i5.1126"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Ojetti V, Pitocco D, Bartolozzi F, Danese S, Migneco A, Lupascu A, Pola P, Ghirlanda G, Gasbarrini G, Gasbarrini A. High rate of helicobacter pylori re-infection in patients affected by type 1 diabetes. Diabetes Care 2002;25:1485.","DOI":"10.2337\/diacare.25.8.1485"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Begue RE, Mirza A, Compton T, Gomez R, Vargas A. Helicobacter pylori infection and insulin requirement among children with type 1 diabetes mellitus. Pediatrics 1999;103:e83.","DOI":"10.1542\/peds.103.6.e83"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Ozdem S, Akcam M, Yilmaz A, Gultekin M, Artan R. Biochemical markers of bone metabolism in children with Helicobacter pylori infection. Dig Dis Sci 2007;52:967-972.","DOI":"10.1007\/s10620-006-9292-0"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Figura N, Gennari L, Merlotti D, Lenzi C, Campagna S, Franci B, Lucani B, Trabalzini L, Bianciardi L, Gonnelli C. Prevalence of Helicobacter pylori infection in male patients with osteoporosis and controls. Dig Dis Sci 2005;50:847-852.","DOI":"10.1007\/s10620-005-2651-4"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Dokmetas HS, Turkay C, Aydin C, Arici S. Prevalence of Helicobacter pylori in patients with primary hyperparathyroidism. J Bone Miner Metab 2001;19:373-377.","DOI":"10.1007\/s007740170007"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Sato H, Abe K, Oshima N, Kawashima K, Hamamoto N, Moritani M, Mak R, Ishihara S, Adachi K, Kawauchi H. Primary hyperparathyroidism with duodenal ulcer and H. pylori infection. Intern Med 2002;41:377-380.","DOI":"10.2169\/internalmedicine.41.377"},{"key":"ref39","unstructured":"Bednarek-Skublewska A, Schabowski J, Majdan M, Baranowicz-Gaszczyk I, Ksiazek A. [Relationships between hyperparathyroidism and Helicobacter pylori infection in long-term hemodialysis patients]. Pol Arch Med Wewn 2001;105:191-196."},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Kyriazanos ID, Sfiniadakis I, Gizaris V, Hountis P, Hatziveis K, Dafnopoulou A, Datsakis K. The incidence of Helicobacter pylori infection is not increased among obese young individuals in Greece. J Clin Gastroenterol 2002;34:541-546.","DOI":"10.1097\/00004836-200205000-00012"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Ioannou GN, Weiss NS, Kearney DJ. Is Helicobacter pylori seropositivity related to body mass index in the United States? Aliment Pharmacol Ther 2005;21:765-772.","DOI":"10.1111\/j.1365-2036.2005.02369.x"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Cho I, Blaser MJ, Francois F, Mathew JP, Ye XY, Goldberg JD, Bini EJ. Helicobacter pylori and overweight status in the United States: data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2005;162:579-584.","DOI":"10.1093\/aje\/kwi237"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Wu MS, Lee WJ, Wang HH, Huang SP, Lin JT. A case-control study of association of Helicobacter pylori infection with morbid obesity in Taiwan. Arch Intern Med 2005;165:1552-1555.","DOI":"10.1001\/archinte.165.13.1552"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Isomoto H, Ueno H, Nishi Y, Wen CY, Nakazato M, Kohno S. Impact of Helicobacter pylori infection on ghrelin and various neuroendocrine hormones in plasma. World J Gastroenterol 2005;11:1644-1648.","DOI":"10.3748\/wjg.v11.i11.1644"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Renshaw AA, Rabaza JR, Gonzalez AM, Verdeja JC. Helicobacter pylori infection in patients undergoing gastric bypass surgery for morbid obesity. Obes Surg 2001;11:281-283.","DOI":"10.1381\/096089201321336601"},{"key":"ref46","unstructured":"Fujiwara Y, Higuchi K, Arafa UA, Uchida T, Tominaga K, Watanabe T, Arakawa T. Long-term effect of Helicobacter pylori eradication on quality of life, body mass index, and newly developed diseases in Japanese patients with peptic ulcer disease. Hepatogastroenterology 2002;49:1298-1302."},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Kamada T, Hata J, Kusunoki H, Ito M, Tanaka S, Kawamura Y, Chayama K, Haruma K. Eradication of Helicobacter pylori increases the incidence of hyperlipidaemia and obesity in peptic ulcer patients. Dig Liver Dis 2005;37:39-43.","DOI":"10.1016\/j.dld.2004.07.017"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Nwokolo CU, Freshwater DA, O’Hare P, Randeva HS. Plasma ghrelin following cure of Helicobacter pylori. Gut 2003;52:637-640.","DOI":"10.1136\/gut.52.5.637"},{"key":"ref49","unstructured":"Konturek PC, Cześnikiewicz-Guzik M, Bielanski W, Konturek SJ. Involvement of Helicobacter pylori infection in neuro-hormonal control of food intake. J Physiol Pharmacol 2006;57 Suppl 5:67-81."},{"key":"ref50","unstructured":"Loffeld RJ. Helicobacter pylori, obesity and gastro-oesophageal reflux disease. Is there a relation? A personal view. Neth J Med 2005;63:344-347."},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Tatsuguchi A, Miyake K, Gudis K, Futagami S, Tsukui T, Wada K, Kishida T, Fukuda Y, Sugisaki Y, Sakamoto C. Effect of Helicobacter pylori infection on ghrelin expression in human gastric mucosa. Am J Gastroenterol 2004;99:2121-2127.","DOI":"10.1111\/j.1572-0241.2004.30291.x"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Shiotani A, Miyanishi T, Uedo N, Iishi H. Helicobacter pylori infection is associated with reduced circulating ghrelin levels independent of body mass index. Helicobacter 2005;10:373-378.","DOI":"10.1111\/j.1523-5378.2005.00343.x"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Osawa H, Nakazato M, Date Y, Kita H, Ohnishi H, Ueno H, Shiiya T, Satoh K, Ishino Y, Sugano K. Impaired production of gastric ghrelin in chronic gastritis associated with Helicobacter pylori. J Clin Endocrinol Metab 2005;90:10-16.","DOI":"10.1210\/jc.2004-1330"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Liew PL, Lee WJ, Lee YC, Chen WY. Gastric ghrelin expression associated with Helicobacter pylori infection and chronic gastritis in obese patients. Obes Surg 2006;16:612-619.","DOI":"10.1381\/096089206776945002"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Azuma T, Suto H, Ito Y, Ohtani M, Dojo M, Kuriyama M, Kato T. Gastric leptin and Helicobacter pylori infection. Gut 2001;49:324-329.","DOI":"10.1136\/gut.49.3.324"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Nishi Y, Isomoto H, Uotani S, Wen CY, Shikuwa S, Ohnita K, Mizuta Y, Kawaguchi A, Inoue K, Kohno S. Enhanced production of leptin in gastric fundic mucosa with Helicobacter pylori infection. World J Gastroenterol 2005;11:695-699.","DOI":"10.3748\/wjg.v11.i5.695"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Gokcel A, Gumurdulu Y, Kayaselcuk F, Serin E, Ozer B, Ozsahin AK, Guvener N. Helicobacter pylori has no effect on plasma ghrelin levels. Eur J Endocrinol 2003;148:423-426.","DOI":"10.1530\/eje.0.1480423"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"de Luis DA, Varela C, de La Calle H, Canton R, de Argila CM, San Roman AL, Boixeda D. Helicobacter pylori infection is markedly increased in patients with autoimmune atrophic thyroiditis. J Clin Gastroenterol 1998;26:259-263.","DOI":"10.1097\/00004836-199806000-00008"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"Franceschi F, Satta MA, Mentella MC, Penland R, Candelli M, Grillo RL, Leo D, Fini L, Nista EC, Cazzato IA. Helicobacter pylori infection in patients with Hashimoto’s thyroiditis. Helicobacter 2004;9:369.","DOI":"10.1111\/j.1083-4389.2004.00241.x"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Arima N, Tsudo M. Extragastric mucosa-associated lymphoid tissue lymphoma showing the regression by Helicobacter pylori eradication therapy. Br J Haematol 2003;120:790-792.","DOI":"10.1046\/j.1365-2141.2003.04170.x"},{"key":"ref61","unstructured":"Figura N, Di Cairano G, Lore F, Guarino E, Gragnoli A, Cataldo D, Giannace R, Vaira D, Bianciardi L, Kristodhullu S. The infection by Helicobacter pylori strains expressing CagA is highly prevalent in women with autoimmune thyroid disorders. J Physiol Pharmacol 1999;50:817-826."},{"key":"ref62","unstructured":"Triantafillidis JK, Georgakopoulos D, Gikas A, Merikas E, Peros G, Sofroniadou K, Cheracakis P, Sklavaina M, Tzanidis G, Konstantellou E. Relation between Helicobacter pylori infection, thyroid hormone levels and cardiovascular risk factors on blood donors. Hepatogastroenterology 2003;50 Suppl 2:cccxviii-ccccccxx."},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"Larizza D, Calcaterra V, Martinetti M, Negrini R, De Silvestri A, Cisternino M, Iannone AM, Solcia E. Helicobacter pylori infection and autoimmune thyroid disease in young patients: the disadvantage of carrying the human leukocyte antigen-DRB1*0301 allele. J Clin Endocrinol Metab 2006;91:176-179.","DOI":"10.1210\/jc.2005-1272"},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"Bertalot G, Montresor G, Tampieri M, Spasiano A, Pedroni M, Milanesi B, Favret M, Manca N, Negrini R. Decrease in thyroid autoantibodies after eradication of Helicobacter pylori infection. Clin Endocrinol (Oxf) 2004;61:650-652.","DOI":"10.1111\/j.1365-2265.2004.02137.x"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"Tomasi PA, Dore MP, Fanciulli G, Sanciu F, Realdi G, Delitala G. Is there anything to the reported association between Helicobacter pylori infection and autoimmune thyroiditis? Dig Dis Sci 2005;50:385-388.","DOI":"10.1007\/s10620-005-1615-z"},{"key":"ref66","unstructured":"Novikova VP, Iur’ev VV, Tkachenko EI, Strukov EL, Liubimov IuA, Antonov PV. [Chronic gastritis in children with concomitant diseases of the thyroid gland]. Eksp Klin Gastroenterol 2003;50:40-43, 114."},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"Cammarota G, De Marinis AT, Papa A, Valle D, Cuoco L, Cianci R, Fedeli G, Gasbarrini G. Gastric mucosa-associated lymphoid tissue in autoimmune thyroid diseases. Scand J Gastroenterol 1997;32:869-872.","DOI":"10.3109\/00365529709011193"},{"key":"ref68","doi-asserted-by":"crossref","unstructured":"Raderer M, Osterreicher C, Machold K, Formanek M, Fiebiger W, Penz M, Dragosics B, Chott A. Impaired response of gastric MALT-lymphoma to Helicobacter pylori eradication in patients with autoimmune disease. Ann Oncol 2001;12:937-939.","DOI":"10.1023\/A:1011122904602"},{"key":"ref69","doi-asserted-by":"crossref","unstructured":"Centanni M, Gargano L, Canettieri G, Viceconti N, Franchi A, Delle Fave G, Annibale B. Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis. N Engl J Med 2006;354:1787-1795.","DOI":"10.1056\/NEJMoa043903"},{"key":"ref70","unstructured":"Majka J, Rog T, Konturek PC, Konturek SJ, Bielanski W, Kowalsky M, Szczudlik A. Influence of chronic Helicobacter pylori infection on ischemic cerebral stroke risk factors. Med Sci Monit 2002;8:CR675-CR684."},{"key":"ref71","doi-asserted-by":"crossref","unstructured":"Chimienti G, Russo F, Lamanuzzi BL, Nardulli M, Messa C, Di Leo A, Correale M, Giannuzzi V, Pepe G. Helicobacter pylori is associated with modified lipid profile: impact on Lipoprotein(a). Clin Biochem 2003;36:359-365.","DOI":"10.1016\/S0009-9120(03)00063-8"},{"key":"ref72","doi-asserted-by":"crossref","unstructured":"Laurila A, Bloigu A, Nayha S, Hassi J, Leinonen M, Saikku P. Association of Helicobacter pylori infection with elevated serum lipids. Atherosclerosis 1999;142:207-210.","DOI":"10.1016\/S0021-9150(98)00194-4"},{"key":"ref73","doi-asserted-by":"crossref","unstructured":"Hoffmeister A, Rothenbacher D, Bode G, Persson K, Marz W, Nauck MA, Brenner H, Hombach V, Koenig W. Current infection with Helicobacter pylori, but not seropositivity to Chlamydia pneumoniae or cytomegalovirus, is associated with an atherogenic, modified lipid profile. Arterioscler Thromb Vasc Biol 2001;21:427-432.","DOI":"10.1161\/01.ATV.21.3.427"},{"key":"ref74","doi-asserted-by":"crossref","unstructured":"Solcia E, Fiocca R, Luinetti O, Villani L, Padovan L, Calistri D, Ranzani GN, Chiaravalli A, Capella C. Intestinal and diffuse gastric cancers arise in a different background of Helicobacter pylori gastritis through different gene involvement. Am J Surg Pathol 1996;20 Suppl 1:S8-S22.","DOI":"10.1097\/00000478-199600001-00003"},{"key":"ref75","doi-asserted-by":"crossref","unstructured":"Niemela S, Karttunen T, Korhonen T, Laara E, Karttunen R, Ikaheimo M, Kesaniemi YA. Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations? Heart 1996;75:573-575.","DOI":"10.1136\/hrt.75.6.573"},{"key":"ref76","doi-asserted-by":"crossref","unstructured":"Danesh J, Peto R. Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. BMJ 1998;316:1130-1132.","DOI":"10.1136\/bmj.316.7138.1130"},{"key":"ref77","doi-asserted-by":"crossref","unstructured":"Takashima T, Adachi K, Kawamura A, Yuki M, Fujishiro H, Rumi MA, Ishihara S, Watanabe M, Kinoshita Y. Cardiovascular risk factors in subjects with Helicobacter pylori infection. Helicobacter 2002;7:86-90.","DOI":"10.1046\/j.1083-4389.2002.00064.x"},{"key":"ref78","doi-asserted-by":"crossref","unstructured":"Ando T, Minami M, Ishiguro K, Maeda O, Watanabe O, Mizuno T, Fujita T, Takahashi H, Noshiro M, Goto H. Changes in biochemical parameters related to atherosclerosis after Helicobacter pylori eradication. Aliment Pharmacol Ther 2006;24 Suppl 4:58-64.","DOI":"10.1111\/j.1365-2036.2006.00026.x"},{"key":"ref79","doi-asserted-by":"crossref","unstructured":"Feingold KR, Grunfeld C. Role of cytokines in inducing hyperlipidemia. Diabetes 1992;41 Suppl 2:97-101.","DOI":"10.2337\/diab.41.2.S97"},{"key":"ref80","unstructured":"Pieniazek P, Karczewska E, Duda A, Tracz W, Pasowicz M, Konturek SJ. Association of Helicobacter pylori infection with coronary heart disease. J Physiol Pharmacol 1999;50:743-751."},{"key":"ref81","doi-asserted-by":"crossref","unstructured":"Kowalski M. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque. J Physiol Pharmacol 2001;52:3-31.","DOI":"10.1016\/S1590-8658(01)80711-8"},{"key":"ref82","doi-asserted-by":"crossref","unstructured":"Fraser AG, Scragg RK, Cox B, Jackson RT. Helicobacter pylori, Chlamydia pneumoniae and myocardial infarction. Intern Med J 2003;33:267-272.","DOI":"10.1046\/j.1445-5994.2003.00349.x"},{"key":"ref83","unstructured":"Al-Nozha MM, Khalil MZ, Al-Mofleh IA, Al-Ghamdi AS. Lack of association of coronary artery disease with H.pylori infection. Saudi Med J 2003;24:1370-1373."},{"key":"ref84","doi-asserted-by":"crossref","unstructured":"Elizalde JI, Pique JM, Moreno V, Morillas JD, Elizalde I, Bujanda L, De Argila CM, Cosme A, Castiella A, Ros E. Influence of Helicobacter pylori infection and eradication on blood lipids and fibrinogen. Aliment Pharmacol Ther 2002;16:577-586.","DOI":"10.1046\/j.1365-2036.2002.01202.x"},{"key":"ref85","doi-asserted-by":"crossref","unstructured":"Adiloglu AK, Can R, Kinay O, Aridogan BC. Infection with Chlamydia pneumoniae but not Helicobacter pylori is related to elevated apolipoprotein B levels. Acta Cardiol 2005;60:599-604.","DOI":"10.2143\/AC.60.6.2004930"},{"key":"ref86","doi-asserted-by":"crossref","unstructured":"Scharnagl H, Kist M, Grawitz AB, Koenig W, Wieland H, Marz W. Effect of Helicobacter pylori eradication on high-density lipoprotein cholesterol. Am J Cardiol 2004;93:219-220.","DOI":"10.1016\/j.amjcard.2003.09.045"},{"key":"ref87","doi-asserted-by":"crossref","unstructured":"Furuta T, Shirai N, Xiao F, Takashima M, Hanai H. Effect of Helicobacter pylori infection and its eradication on nutrition. Aliment Pharmacol Ther 2002;16:799-806.","DOI":"10.1046\/j.1365-2036.2002.01222.x"},{"key":"ref88","doi-asserted-by":"crossref","unstructured":"Figura N, Piomboni P, Ponzetto A, Gambera L, Lenzi C, Vaira D, Peris C, Lotano MR, Gennari L, Bianciardi L. Helicobacter pylori infection and infertility. Eur J Gastroenterol Hepatol 2002;14:663-669.","DOI":"10.1097\/00042737-200206000-00012"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v15\/i22\/2701.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T09:24:25Z","timestamp":1633598665000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v15\/i22\/2701.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":88,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.15.2701","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}